Moxifloxacin CAS#151096-09-2

Moxifloxacin CAS#151096-09-2, this synthetic fluoroquinolone antibiotic is known for its potent antibacterial activity. Moxifloxacin works by inhibiting the enzymes DNA gyrase and topoisomerase IV, which are essential for bacterial DNA replication. This interference disrupts the growth and multiplication of bacteria, leading to their elimination.

In terms of chemical properties, moxifloxacin CAS#151096-09-2 is a yellowish crystalline powder. It has a molecular formula of C₂₁H₂₄FN₃O₄ and a molecular weight of 401.43. It is sparingly soluble in water but dissolves well in organic solvents.

One of the key features of moxifloxacin CAS#151096-09-2 is its broad spectrum of activity. It is effective against a wide range of gram-positive and gram-negative bacteria, including some of the most common pathogens that cause respiratory tract infections, skin and soft tissue infections, and intra-abdominal infections. For example, it is active against Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, Staphylococcus aureus, and Escherichia coli.

Moxifloxacin CAS#151096-09-2 is available in various formulations, including tablets, injections, and eye drops. This allows for flexible administration depending on the type and severity of the infection. In oral form, it is easily absorbed from the gastrointestinal tract and reaches therapeutic levels in the body quickly.

In the treatment of respiratory tract infections, moxifloxacin CAS#151096-09-2 has shown excellent efficacy. It is often prescribed for community-acquired pneumonia, acute bacterial sinusitis, and chronic obstructive pulmonary disease exacerbations. Its ability to penetrate into respiratory tissues and cells makes it particularly useful in treating infections in these areas.

For skin and soft tissue infections, moxifloxacin CAS#151096-09-2 can effectively combat a variety of bacteria that cause these conditions. It is an important option for patients with mild to moderate infections as well as those with more severe infections that may require hospitalization.

In addition to its antibacterial activity, moxifloxacin CAS#151096-09-2 has some other advantages. It has a relatively long half-life, which means that it can be administered less frequently than some other antibiotics. This can improve patient compliance and convenience.

However, like all antibiotics, moxifloxacin should be used judiciously to prevent the development of antibiotic resistance. Healthcare providers need to consider the specific pathogen, the severity of the infection, and the patient's individual characteristics when prescribing moxifloxacin.

In conclusion, moxifloxacin CAS#151096-09-2 is a valuable antibiotic with broad-spectrum activity and several advantages in the treatment of various infections. Its efficacy, ease of administration, and relatively long half-life make it an important tool in the fight against bacterial infections.

Hot Tags: Moxifloxacin CAS#151096-09-2, China Moxifloxacin CAS#151096-09-2 manufacturers, suppliers, , Biopharmaceuticals, , 4-bromopyridine hydrochloride